Johnson & Johnson raises 2026 guidance: stock pre-market at EUR 222.50, plus 0.16 percent

Published on 10/14/2026 at 07:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson raised its 2026 adjusted EPS guidance to $11.10 after reporting third-quarter sales of $25.4 billion. The stock was EUR 222.50 pre-market at Lang & Schwarz, up 0.16 percent.

Guidance and dates ahead

Johnson & Johnson reported third-quarter 2026 sales of $25.4 billion on October 13, 2026.
Johnson & Johnson stock trades pre-market at EUR 222.50 at 7:42 a.m. CEST at Lang & Schwarz on October 14, 2026, 0.16 percent above the Xetra close of October 13, 2026.
The company’s fourth-quarter dividend has an ex-dividend date of November 24, 2026.
A round-number reference of EUR 223.00 is 0.22 percent above the pre-market price.
The declared fourth-quarter dividend is $1.34 per share, payable December 8, 2026.

Black and white documentary photograph of a bearded pediatrician pressing a stethoscope to the chest of a young smiling child seated on an examination table, soft window light from the left, fine film grain, clinical room softly blurred in the background — Johnson Kinderarzt untersucht ein Kind mit Stethoskop, US4781601046 steht für humane Medizin, Illustration mit AI erstellt.

Johnson & Johnson reported third-quarter 2026 results and raised its full-year guidance on October 13, 2026, according to the company’s press release. At 7:42 a.m. CEST on October 14, 2026, the stock was at EUR 222.50 in pre-market trading at Lang & Schwarz, 0.16 percent above the Xetra close of October 13, 2026, at EUR 222.15. The bid was EUR 222.00 and the ask was EUR 223.00. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.

Third-quarter results and outlook

Reported third-quarter sales rose 5.9 percent to $25.4 billion, while diluted earnings per share were $0.09. Adjusted diluted EPS was $2.59. Johnson & Johnson set its estimated reported 2026 sales midpoint at $101.2 billion and its adjusted diluted EPS midpoint at $11.10, according to the company release.

Dividend schedule

Johnson & Johnson’s board declared a fourth-quarter 2026 cash dividend of $1.34 per share on October 13, 2026. The dividend is payable December 8, 2026, to shareholders of record at the close of business on November 24, 2026, and the ex-dividend date is November 24, 2026, the company said in a separate release.

What matters today: The next company-specific date is November 24, 2026, the ex-dividend date. A round-number reference is EUR 223.00, which is 0.22 percent above the pre-market price. The most recent declared dividend is $1.34 per share, payable December 8, 2026.